CN Patent
CN106474058B — 具有延长的保质期的阿立哌唑可注射悬浮液制剂
Assigned to Nanjing Noratech Pharmaceuticals Co ltd · Expires 2020-01-07 · 6y expired
What this patent protects
本发明属于药物制剂领域,具体涉及一种具有延长的保质期的阿立哌唑可注射悬浮液制剂,及应用上述制剂治疗精神分裂症以及相关疾病的方法。另一方面,本发明亦涉及一种延长阿立哌唑可注射悬浮液制剂的保质期的方法。
USPTO Abstract
本发明属于药物制剂领域,具体涉及一种具有延长的保质期的阿立哌唑可注射悬浮液制剂,及应用上述制剂治疗精神分裂症以及相关疾病的方法。另一方面,本发明亦涉及一种延长阿立哌唑可注射悬浮液制剂的保质期的方法。
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.